Temozolomide as a single agent maintenance therapy in elderly patients with Primary CNS Lymphoma
ConclusionThese outcomes suggest that TMZ may have activity for maintenance in elderly patients with PCNSL, when more aggressive treatments are contraindicated.
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research
More News: Brain | Cancer & Oncology | Leukemia | Lymphoma | Methotrexate | Myeloma | Neurology | Primary CNS Lymphoma | Rituxan | Stem Cell Therapy | Stem Cells | Temodar | Thrombocytopenia | Toxicology | Transplants